Page last updated: 2024-08-22

palladium and mdl 100907

palladium has been researched along with mdl 100907 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arlt, M; Beller, M; Böttcher, H; Garcia Castro, I; Heinrich, T; Kumar, K; Michalik, D; Tillack, A; Zapf, A	1
Butini, S; Cagnotto, A; Campiani, G; Carminati, P; Catalanotti, B; Di Cesare, MA; Di Serio, S; Fattorusso, C; Fiorini, I; Gemma, S; Ghirardi, O; Mennini, T; Mereghetti, I; Minetti, P; Nacci, V; Stasi, MA; Tinti, O; Trotta, F	1

Other Studies

2 other study(ies) available for palladium and mdl 100907

Article	Year
Biologically active compounds through catalysis: efficient synthesis of N-(heteroarylcarbonyl)-N'-(arylalkyl)piperazines. Chemistry (Weinheim an der Bergstrasse, Germany), 2004, Feb-06, Volume: 10, Issue:3 Topics: Amination; Catalysis; Molecular Structure; Palladium; Piperazines; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists	2004
Novel atypical antipsychotic agents: rational design, an efficient palladium-catalyzed route, and pharmacological studies. Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6 Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzazepines; Binding Sites; Catalepsy; Catalysis; Cell Line; Crystallography, X-Ray; Dopamine D2 Receptor Antagonists; Drug Design; In Vitro Techniques; Mice; Models, Molecular; Molecular Conformation; Palladium; Pyrroles; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship	2005

Article

Year

Biologically active compounds through catalysis: efficient synthesis of N-(heteroarylcarbonyl)-N'-(arylalkyl)piperazines.

Chemistry (Weinheim an der Bergstrasse, Germany), 2004, Feb-06, Volume: 10, Issue:3

Topics: Amination; Catalysis; Molecular Structure; Palladium; Piperazines; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists

2004

Novel atypical antipsychotic agents: rational design, an efficient palladium-catalyzed route, and pharmacological studies.

Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6

Topics: Animals; Antipsychotic Agents; Avoidance Learning; Benzazepines; Binding Sites; Catalepsy; Catalysis; Cell Line; Crystallography, X-Ray; Dopamine D2 Receptor Antagonists; Drug Design; In Vitro Techniques; Mice; Models, Molecular; Molecular Conformation; Palladium; Pyrroles; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship

2005